Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma

Silvia Pietrobono (Lead / Corresponding author), Eugenio Gaudio, Sinforosa Gagliardi, Mariapaola Zitani, Laura Carrassa, Francesca Migliorini, Elena Petricci, Fabrizio Manetti, Nikolai Makukhin, Adam G. Bond, Brooke D. Paradise, Alessio Ciulli, Martin E. Fernandez-Zapico, Francesco Bertoni, Barbara Stecca (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)
35 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences